ArticleCold Spring Harbor molecular case studies2018
A recurrent novel
Open access · diamondAbstract readCase Reports
In one paragraph
Article in Cold Spring Harbor molecular case studies, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 52 citations in OpenAlex.
- International guidelines on the diagnosis and treatment of NUT carcinoma.Innovation (Cambridge (Mass.)) · 2026Review
- Expanding the spectrum of non-canonical NUT carcinoma: clinicopathological and molecular characterization ofFrontiers in oncology · 2026Article
- Advancing Understanding and Therapeutic Strategies for NUT Sarcomas: Comprehensive Review of the Literature and Two Cases.Journal of immunotherapy and precision oncology · 2025Review
- Molecular Landscape of Endometrial Stromal Tumors.JCO precision oncology · 2025Article
- Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.Nature reviews. Clinical oncology · 2025Review
- Case Report: NUTM1-rearranged lung sarcoma: a rare case imaged with dynamic and staticFrontiers in oncology · 2025Article
- The histological spectrum and immunoprofile of head and neck NUT carcinoma: A multicentre series of 30 cases.Histopathology · 2024Article
- [Research Progress on Pathogenesis and Treatment of NUT Carcinoma].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2024Review
- Spindle cell sarcoma of the chest wall: a pediatric case report.Journal of surgical case reports · 2024Article
- The expanding universe of NUTM1 fusions in pediatric cancer.Clinical and translational science · 2023Review
- Clonal evolution during metastatic spread in high-risk neuroblastoma.Nature genetics · 2023Article
- Nuclear protein in testis carcinoma of the lung.Translational oncology · 2023Review
- Small round cell sarcomas.Nature reviews. Disease primers · 2022Review
- NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.Frontiers in oncology · 2022Review
- Skin adnexal carcinoma with BRD3-NUTM2B fusion.Journal of cutaneous pathology · 2021Article
- Review
- NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021Article
- Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma.Frontiers in oncology · 2021Review
- Case Report and Literature Review: Primary Pulmonary NUT-Midline Carcinoma.Frontiers in oncology · 2021Article
- A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.Laboratory investigation; a journal of technical methods and pathology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 3 institutions in 1 country.
Daniel Diolaiti *Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Filemon S Dela Cruz *Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Gunes GundemDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Nancy BouvierDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Mathieu BouladDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Yanming ZhangDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Alexander J ChouDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Ira J DunkelDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Rashesh SanghviNew York Genome Center, New York, New York 10013, USA.
Minita ShahNew York Genome Center, New York, New York 10013, USA.
Heather GeigerNew York Genome Center, New York, New York 10013, USA.
Sadia RahmanNew York Genome Center, New York, New York 10013, USA.
Vanessa FeliceNew York Genome Center, New York, New York 10013, USA.
Kazimierz O WrzeszczynskiNew York Genome Center, New York, New York 10013, USA.
Robert B DarnellNew York Genome Center, New York, New York 10013, USA.
Cristina R AntonescuDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Christopher A FrenchDepartment of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts 02115, USA.
Elli PapaemmanuilDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Andrew L KungDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Neerav ShuklaDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Memorial Sloan Kettering Cancer Center · USNew York Genome Center · USBrigham and Women's Hospital · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MTargeting Oncogenic Pathways in Genetically Complex SarcomasP50CA217694 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI William D. Tap · 2018 to 2026
$21.5MNCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Indexed as
Basic Helix-Loop-Helix ProteinsBiomarkers, TumorCell DifferentiationChildFemaleGene FusionGene RearrangementHumansImmunohistochemistryMaleNeoplasm ProteinsNuclear ProteinsOncogene Proteins, FusionRecombination, GeneticSarcomaSarcoma, SynovialBasic Helix-Loop-Helix ProteinsBiomarkers, TumorMGA protein, humanNeoplasm ProteinsNuclear ProteinsNUTM1 protein, humanOncogene Proteins, FusionTranscription FactorsMGA-NUT1NUT carcinomaNUTM1-rearranged tumorspindle cell carcinomasynovial sarcoma
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.